Paratek

@ParatekPharma

Paratek ($PRTK) is a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry.

Vrijeme pridruživanja: srpanj 2015.

Tweetovi

Blokirali ste korisnika/cu @ParatekPharma

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ParatekPharma

  1. 20. sij

    More must be done - including the passage of the DISARM Act - to address the crisis

    Poništi
  2. 17. sij

    "Push" and "pull" incentives are both critical to fighting yet 's Project Bioshield contract awarded to late last year is the only pull incentive implemented to date; urgent action is needed

    Poništi
  3. proslijedio/la je Tweet
    14. sij

    Excellent podcast from on the need for Medicare reimbursement reform for antibiotics

    Poništi
  4. 10. sij

    Research published in reports using multiple could speed up resistance, extremely small study but important as we continue to fight and promote

    Poništi
  5. 9. sij

    We need to move quickly to change the trajectory of antibiotic development and protect public health. Thank you for your thoughtful opinion piece.

    Poništi
  6. proslijedio/la je Tweet
    20. pro 2019.

    & will work together to protect this nation from bioterror attacks. Let’s make sure that the government continues to see the importance of developing antibiotics to save lives. Visit to learn more.

    Poništi
  7. 19. pro 2019.

    Paratek began developing NUZYRA for potential use against bioterrorism threats a decade ago. We are pleased to work with to continue this work.

    Poništi
  8. 19. pro 2019.

    Thank you and for your commitment to this innovative public-private partnership

    Poništi
  9. 19. pro 2019.

    ICYMI: A replay of the conference call on the details of the new BARDA contract to develop NUZYRA for biodefense purposes is now available here:

    Poništi
  10. 18. pro 2019.

    announces 5-yr BARDA contract to develop and supply NUZYRA for treatment of potential biothreats. Total award valued at up to $285 million. Details here:

    Poništi
  11. 21. stu 2019.

    Important perspective on from as we continue the fight against antimicrobial resistance

    Poništi
  12. proslijedio/la je Tweet

    "How soon do you need new ?" "Well, we need them yesterday," - highlights the frightening landscape facing doctors fighting drug-resistant pathogens and what needs to be done to help them.

    Poništi
  13. 14. stu 2019.

    Check out Paratek on ! Our CEO and President Adam Woodrow talk about the importance of the availability of new agents in fighting infections and legislative support to enable continued innovation in development.

    Poništi
  14. 13. stu 2019.

    Today's report paints a grim picture of . One bright spot: progress in prevention and treatment in the hospital setting. We're proud to be on the front lines providing doctors with a new option.

    Poništi
  15. 13. stu 2019.

    ICYMI: A replay of the third quarter financial results conference call is now available

    Poništi
  16. 12. stu 2019.

    Paratek Pharmaceuticals ($PRTK) Reports Third Quarter Financial Results

    Poništi
  17. 12. stu 2019.

    Reminder: will host a webcast today at 4:30 p.m. EDT to report Q3 financial results. Details here:

    Poništi
  18. 7. stu 2019.

    We appreciate the important work and are doing to advance policy solutions to help address one of today's biggest health challenges, antimicrobial resistance, and protect the health of our country.

    Poništi
  19. 5. stu 2019.

    will host a webcast on Tues, November 12 at 4:30 p.m. EDT to report Q3 financial results. Details here:

    Poništi
  20. proslijedio/la je Tweet

    ., Chief Executive Officer of and Chairman of the AWG, comments on AWG's presence at . For more information on AWG member company presentations and access to specific abstracts, please visit:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·